Reuters logo
BRIEF-Biomerieux receives FDA clearance for BioFire’s FilmArray Respiratory Panel 2 (RP2)
June 1, 2017 / 5:14 AM / 6 months ago

BRIEF-Biomerieux receives FDA clearance for BioFire’s FilmArray Respiratory Panel 2 (RP2)

June 1 (Reuters) - BIOMERIEUX SA:

* BIOMÉRIEUX RECEIVES FDA CLEARANCE FOR BIOFIRE’S FILMARRAY RESPIRATORY PANEL 2 (RP2)

* BIOMÉRIEUX RECEIVES FDA CLEARANCE FOR BIOFIRE‘S FILMARRAY RESPIRATORY PANEL 2 (RP2)

* ‍FILMARRA RP2 REDUCES SAMPLE-TO-RESULT TIME TO ONLY 45 MINUTES WHILE ENHANCING PATHOGEN COVERAGE AND OVERALL SENSITIVITY​

* FILMARRAY RP2 REDUCES SAMPLE-TO-RESULT TIME TO ONLY 45 MINUTES WHILE ENHANCING PATHOGEN COVERAGE AND OVERALL SENSITIVITY

* ‍FOLLOWS ANNOUNCEMENT IN APRIL THAT FILMARRAY(®) RESPIRATORY PANEL 2 PLUS (RP2PLUS) IS CE MARKED​ SOURCE TEXT FOR EIKON: FURTHER COMPANY COVERAGE: (Gdynia Newsroom:)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below